Latest News

In early March 2026, Helus Pharma, a Cybin company, reported positive topline Phase 2 results for HLP004 as an adjunctive treatment for adults with moderate-to-severe generalized anxiety disorder who remained symptomatic despite standard antidepressant therapy, showing clinically meaningful anxiety score reductions, durable response and remission rates, and a favorable tolerability profile. The findings highlight HLP004’s commercially practical intramuscular administration with short...

Propel Holdings Inc. recently reported its 2025 results, with full-year revenue rising to US$589.81 million and net income to US$59.52 million, alongside a weaker fourth quarter where earnings were weighed down by higher credit costs and new initiative start-up expenses. At the same time, Propel advanced its expansion plans by launching Propel Bank and preparing the Freshline unsecured loan product, supported by a US$60 million receivables purchase agreement with Mesirow Alternative Credit...

Sumitomo Mitsui Trust Group has announced a sweeping leadership refresh, with Kazuya Oyama set to become CEO, Masanori Watanabe appointed CFO, and Amova AM president and CEO Stefanie Drews taking on a new global asset management officer role from 1 April 2026. By elevating Drews to represent the group’s asset management business externally while she continues leading Amova AM, the group is placing unusual emphasis on unifying its global asset management presence under a seasoned...

Life Time Group Holdings (NYSE:LTH) has approved a new $500 million share repurchase program. The buyback plan targets the company's common stock and is intended to support long term shareholder value. This authorization adds a fresh capital allocation lever for the fitness and lifestyle operator. Life Time Group Holdings, trading at $26.12 per share, is coming off a mixed share price run, with a 51.2% gain over three years but a 13.3% decline over the past year. In the shorter term, the...

CRISPR Therapeutics reported a threefold increase in Casgevy patient initiations for sickle cell disease and beta thalassemia over the past year. The company highlighted ongoing commercial rollout progress alongside continued net losses. Management pointed to a strong cash position as support for both Casgevy expansion and further R&D. CRISPR Therapeutics, trading on NasdaqGM:CRSP, is in the spotlight as Casgevy gains early traction in the gene therapy market. The stock closed at $57.33,...

In late February 2026, Recursion Pharmaceuticals reported fourth-quarter 2025 revenue of US$35.54 million with a quarterly net loss of US$108.12 million, and around the same time filed a US$300 million at-the-market follow-on equity offering plus a US$68.57 million shelf registration tied to an ESOP. Shortly after these filings, Director Blake Borgeson sold 170,000 Class A shares while still retaining more than 6.25 million shares, drawing attention to insider sentiment alongside the...

Huhtamäki Oyj overview after recent share performance Huhtamäki Oyj (HLSE:HUH1V) has seen its share price move modestly in recent weeks, with a roughly flat return over the past month and a slightly positive performance across the past 3 months. See our latest analysis for Huhtamäki Oyj. The recent 7 day share price return of a 4.28% decline contrasts with a 1 year total shareholder return of a 14.52% decline and a 3 year total shareholder return that is slightly positive, suggesting momentum...

Event overview and why NRG Energy is on investors’ radar NRG Energy (NRG) has attracted fresh attention after a strong 1 year total return of 78.24%, standing out against more muted recent moves over the past week and month. That contrast between short term pullback and longer term strength is prompting investors to reassess how the company’s US$30,713.0m in revenue and US$797.0m in net income line up with current pricing. See our latest analysis for NRG Energy. At a share price of US$160.46,...

Assessing Acushnet Holdings after recent share price moves Acushnet Holdings (GOLF) has recently seen mixed share price performance, with a 2.3% decline over the past day and a 5.6% decline over the past week, alongside gains over the past 3 months and year. See our latest analysis for Acushnet Holdings. Putting that into context, the recent 1-day and 7-day share price declines sit against a stronger 90-day share price return of 16.4% and a 1-year total shareholder return of 44.0%. This...

JBS stock snapshot and recent performance JBS (NYSE:JBS) has recently drawn investor attention as its shares trade around $15.65, with returns showing mixed short term moves and a positive shift over the past 3 months and year to date. See our latest analysis for JBS. Despite a recent 1-day share price return decline of 4.16% and a 7-day share price return decline of 5.89%, JBS still shows a 90-day share price return of 9.06% and a year to date share price return of 10.37%. This suggests...

BHP Group’s recent participation at the 35th BMO Global Metals, Mining & Critical Minerals Conference in Florida highlighted CEO Mike Henry’s emphasis on capital discipline and future-facing commodities such as copper amid pressure on its Queensland coal assets and iron ore relationships with Chinese buyers. At the same time, geopolitical tensions, unprofitable coal operations, and China’s procurement restrictions on some BHP iron ore products have tightened the focus on how resilient BHP’s...

Oil price shock and inflation fears hit Atmus Filtration Technologies (ATMU) Atmus Filtration Technologies (ATMU) came under pressure after crude oil prices jumped on escalating conflict with Iran, raising concerns about renewed inflation and the prospect of more challenging central bank interest rate decisions. See our latest analysis for Atmus Filtration Technologies. Despite the latest 2.97% 1 day share price decline to $61.84, Atmus Filtration Technologies still has a 1 month share price...

Huntington Bancshares at a glance Huntington Bancshares (HBAN) has drawn attention after recent share price weakness, with the stock down about 9% over the past month and modestly lower over the past 3 months. At a last close of $16.68, the regional bank carries a value score of 3 and reports annual revenue of $7,692.0 and net income of $2,087.0, both stated with positive annual growth rates. See our latest analysis for Huntington Bancshares. The recent 9.3% 30 day share price decline and...

China's National Development and Reform Commission has announced a policy to boost intellectual property driven consumer spending. The policy aims to deepen collaborations between consumer brands and well known IPs across toys, entertainment and retail. Pop Mart International Group (SEHK:9992), a major player in branded collectibles, is directly exposed to this policy shift. The move is designed to support consumption and IP commercialization within China, with implications for both domestic...

Zoom Communications (ZM) is back in focus after a sector wide rally spotlighted enterprise software names, just days after the company reported quarterly results that exceeded its guidance midpoint for a third straight time. See our latest analysis for Zoom Communications. Even after the sector rally and the latest earnings beat, Zoom’s share price of US$77.33 sits below its recent highs, with a 30 day share price return of 12.85% decline and a year to date share price return of 7.19%...

If you are wondering whether Magnum Ice Cream shares offer fair value at today’s price or if the market is missing something, this article walks you through what the numbers are actually saying about the stock. After a recent last close of €13.07, the share price has seen a 3.0% decline over the last week and a 13.3% decline over the last 30 days, with a 1.7% decline year to date that may have some investors rethinking the balance between potential upside and risk. Recent coverage around...

Executives at Travelers Companies (NYSE:TRV) have recently carried out significant insider share sales, drawing attention to management's trading activity. The company has reported strong operating performance supported by underwriting gains, higher investment income, and efficiencies linked to AI tools. Travelers Companies sits at a current share price of $306.64. The stock is up 21.7% over the past year, 85.7% over the past 3 years, and 117.4% over the past 5 years. For investors looking...

Las Vegas Sands (LVS) has put fresh leadership at the center of its story, with Patrick Dumont now serving as chairman, chief executive officer, president, and treasurer, alongside new five year agreements for other senior executives. See our latest analysis for Las Vegas Sands. The leadership reshuffle lands at a time when the share price has eased back, with a 90 day share price return of 16.77% decline and a year to date share price return of 15.44% decline. At the same time, the 1 year...

Earnings, dividend and buyback update shape Winpak’s latest market story Winpak (TSX:WPK) has just released fourth quarter and full year 2025 results, alongside a fresh dividend declaration and an update on its ongoing share repurchase program, giving investors several moving pieces to assess at once. See our latest analysis for Winpak. Winpak shares now trade at CA$47.75, with a 30 day share price return of 7.71% and a 90 day return of 10.38%. The 1 year total shareholder return of 25.10%...

OmniAb (OABI) has posted its FY 2025 numbers with Q4 revenue of US$8.4 million and a basic EPS loss of US$0.11, alongside a trailing twelve month revenue figure of US$18.7 million and a basic EPS loss of US$0.57. Over recent quarters, the company has reported quarterly revenue in a range between US$2.2 million and US$10.8 million, while basic EPS losses have ranged from US$0.11 to US$0.17, leaving margins in loss-making territory and keeping the focus on how efficiently that revenue is being...

Recent share performance and business snapshot Zhongsheng Group Holdings (SEHK:881) has been under pressure recently, with the share price showing negative returns over the past week, month, past 3 months, year, and on a 3 year and 5 year view. At a last close of HK$9.41, the company sits against a backdrop of HK$163,024.88m in revenue and HK$2,643.99m in net income. Annual revenue and net income growth figures are moving in different directions. See our latest analysis for Zhongsheng Group...

If you are wondering whether Power Integrations is attractively priced right now, it helps to separate the share price story from what the underlying valuation is actually saying. The stock closed at US$47.81 most recently, after a 5.7% gain over the last 30 days, with a 28.2% return year to date, alongside an 18.3% decline over the past year and a 40.0% decline over five years. Recent attention on Power Integrations has centered on its position in the semiconductor space and how investors...

Lam Research (LRCX) shares dropped after renewed concerns about Middle East tensions, with investors reacting to potential energy price shocks, higher liquefied natural gas costs in South Korea, and possible new AI chip export rules. See our latest analysis for Lam Research. The recent 3.7% one day share price drop to US$214.68 and 10.2% 7 day share price decline come after months of strong momentum, with a 35.3% 90 day share price return and very large multi year total shareholder returns...

Shift in major shareholder stake puts Noritake (TSE:5331) ownership in focus Strategic Capital cutting its holding in Noritake (TSE:5331) from 9.38% to 8.20%, as disclosed in a regulatory filing, puts fresh attention on who holds the shares and how ownership is evolving. See our latest analysis for Noritake. Noritake’s ¥6,590 share price comes after a 4.1% one day share price return and a 21.8% 90 day share price return, while the one year total shareholder return of 87.7% and five year total...